What Does the Evidence Say About Microdosing for Fat Loss Clinical trials proving GLP 1 benefits were performed in people with obesity using full therapeutic doses not microdosing glp 1 or tirzepatide microdosing
For significant weight loss (100 lbs or more), especially if it occurred rapidly, the skin may not fully retract without intervention
Tatone-Tokuda F, Dubois L, Ramsay T, Girard M, Touchette E, Petit D, et al
Whilst GLP-1 receptor agonists act on brain reward centres and some patients report reduced desire for sweet foods, there is no official established link to targeted sugar craving reduction
This shift towards exploring its broader applications reflects a growing interest in holistic health approaches, making microdosing a topic of increasing relevance
Goldman Sachs puts it at $130 billion by that year all up from single digits as recently as 2023